Home | Contact | Sitemap | Restricted area
Home » non-clinical
Iris Pharma is dedicated to non-clinical studies
Iris Pharma is a French Contract Research Organization (CRO) dedicated to non-clinical and clinical studies in ophthalmology.
Founded in 1989 by Pierre-Paul Elena, Ph.D., Iris Pharma provides non-clinical services and clinical research services to Biotechnology, Pharmaceutical Industries and Institutes.
Iris Pharma is the first worldwide CRO that is specializing in carrying out Phase I, Phase II, Phase III and Phase IV as well as non-clinical services.
Aside non-clinical studies our company works in different areas: GLP bioanalytical testing, pre-clinical services formulation, clinical trials in ophthalmology, ocular drug development etc.
Founded in 1989 by Pierre-Paul Elena, Ph.D., Iris Pharma provides non-clinical services and clinical research services to Biotechnology, Pharmaceutical Industries and Institutes.
Iris Pharma is the first worldwide CRO that is specializing in carrying out Phase I, Phase II, Phase III and Phase IV as well as non-clinical services.
Non-clinical studies and in-depth studies
Iris Pharma provides :- Non-clinical research in ophthalmology: a unit managing the complete animal development of drugs and devices.
- Basic non-clinical research in ophthalmology: customized studies for new drugs, devices, and methods development.
- Non-clinical formulation
Non-clinical research and a complete range of services
Iris Pharma is a leading provider of in-vivo non-clinical services for drug and device development in ophthalmology.Aside non-clinical studies our company works in different areas: GLP bioanalytical testing, pre-clinical services formulation, clinical trials in ophthalmology, ocular drug development etc.

Copyright 2008 © Iris Pharma - Conception CKC-Net.com
